Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Fabien B Vincent"'
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/b33a4c97c9a2499a8548d1f48ff5188f
Autor:
Fabien B Vincent, Alberta Y Hoi, Fabienne Mackay, James Harris, Rangi Kandane-Rathnayake, Eric F Morand, Rachel Koelmeyer
Publikováno v:
Lupus Science and Medicine, Vol 7, Iss 1 (2020)
Objective Fas/Fas ligand (FasL) and B cell-activating factor (BAFF) signalling have pivotal roles in SLE pathogenesis. We investigated the clinical associations of serum concentrations of soluble Fas (sFas) and soluble FasL (sFasL) in SLE and their r
Externí odkaz:
https://doaj.org/article/7b8efdbe5c634d4ea13665c983be4fa5
Autor:
Sudha Raghunath, Yifat Glikmann-Johnston, Fabien B. Vincent, Eric F. Morand, Julie C. Stout, Alberta Hoi
Publikováno v:
Journal of the International Neuropsychological Society. 29:421-430
Objective:Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, in which cognitive dysfunction is common, but poorly understood. This study aims to characterize the prevalence and patterns of cognitive dysfunction in SLE.Method:SLE pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef79aad2093b1e86ac5f3151439b9ffc
https://doi.org/10.1017/s1355617722000418
https://doi.org/10.1017/s1355617722000418
Autor:
Hieu T. Nim, Kathryn Connelly, Fabien B. Vincent, François Petitjean, Alberta Hoi, Rachel Koelmeyer, Sarah E. Boyd, Eric F. Morand
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Objective: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. SLE is characterized by high inter-patient variability, including fluctuations over time, a factor which most biomarker studies omit from consideration. We investigate
Externí odkaz:
https://doaj.org/article/294a50dd7d73469da14b9f32de68945c
Autor:
Rachel Mende, Fabien B. Vincent, Rangi Kandane-Rathnayake, Rachel Koelmeyer, Emily Lin, Janet Chang, Alberta Y. Hoi, Eric F. Morand, James Harris, Tali Lang
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease characterized by biological and clinical heterogeneity. The interleukin (IL)-1 superfamily is a group of innate cytokines that contribute to pathogenesis in many autoimmun
Externí odkaz:
https://doaj.org/article/ca6d24fb0c3c4a3882590d8d78ffeab1
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 3, Pp 758-770 (2021)
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease
Systemic lupus erythematosus (lupus) is an autoimmune disease characterized by autoantibodies that form immune complexes with self‐antigens, which deposit in various tissues, leading to inflammation and disease. The etiology of disease is complex a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f8e6309e1ccacc7f572687d02f49762
https://doaj.org/article/4fc8bab9e431498f8c54b235ab022d0e
https://doaj.org/article/4fc8bab9e431498f8c54b235ab022d0e
Autor:
Fabienne Mackay, Quentin Pascal, Juliette Pascaud, Bineta Ly, Salima Hacein-Bey, Thierry Lazure, Xavier Mariette, Audrey Paoletti, Sandrine Roulland, Raphaèle Seror, Carole Nicco, Fabien B. Vincent, Frédéric Batteux, Sophie Ferlicot, Roman Krzysiek, Gaetane Nocturne, Lev Stimmer
Publikováno v:
Clin Exp Immunol
Clinical and Experimental Immunology
Clinical and Experimental Immunology, 2021, 205 (2), pp.169-181. ⟨10.1111/cei.13602⟩
Clinical and Experimental Immunology
Clinical and Experimental Immunology, 2021, 205 (2), pp.169-181. ⟨10.1111/cei.13602⟩
Summary The impact of treatment on the risk of lymphoma in patients with rheumatoid arthritis (RA) is unclear. Here, we aimed to assess if the risk of lymphoma differs according to the type of tumor necrosis factor inhibitor (TNFi), comparing monoclo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a72a28d3ce55be58f4ce49cc00abcb
https://doi.org/10.1111/cei.13602
https://doi.org/10.1111/cei.13602
Autor:
Danielle M. Santarelli, Fabien B. Vincent, Ina Rudloff, Claudia A. Nold-Petry, Marcel F. Nold, Marc A. Russo
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Interleukin (IL)-37 has an important function in limiting excessive inflammation. Its expression is increased in numerous inflammatory and autoimmune conditions and correlates with disease activity, suggesting it could have potential as a disease bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc8704e5a9dcd5092c4a8773d4f3bd1
https://www.frontiersin.org/articles/10.3389/fimmu.2021.708425/full
https://www.frontiersin.org/articles/10.3389/fimmu.2021.708425/full
Autor:
Jacqueline K. Flynn, Linden J. Gearing, Wendy Dankers, Fabien B. Vincent, Megan A. Cristofaro, James Harris, Joshua D. Ooi, Abul Hasnat, Rochelle Sherlock, Champa Nataraja, Mehnaz Pervin, Wendy Zhu, Eric F Morand, Jacinta P. W. Lee, Sarah A. Jones
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in immunology, 12:652800. Frontiers Media S.A.
Frontiers in Immunology
Frontiers in immunology, 12:652800. Frontiers Media S.A.
Frontiers in Immunology
Glucocorticoid-induced leucine zipper (GILZ) mimics many of the anti-inflammatory effects of glucocorticoids, suggesting it as a point of therapeutic intervention that could bypass GC adverse effects. We previously reported that GILZ down-regulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::255f5493f129b64fdd655652deb3b7cd
https://www.frontiersin.org/articles/10.3389/fimmu.2021.652800/full
https://www.frontiersin.org/articles/10.3389/fimmu.2021.652800/full
Publikováno v:
Pathogenesis of Systemic Lupus Erythematosus ISBN: 9783030851606
Most high-profile clinical trials of targeted therapies, including those targeting B cells, have failed in systemic lupus erythematosus (SLE). Currently, only one biological therapy has been approved for this condition, belimumab, a monoclonal antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9df189a01592340128f023154e2c4c7
https://doi.org/10.1007/978-3-030-85161-3_3
https://doi.org/10.1007/978-3-030-85161-3_3
